NUBPL mitochondrial disease: new patients and review of the genetic and clinical spectrum

Kimonis, Virginia, al Dubaisi, Rehab, Maclean, Andrew E, Hall, Kathy, Weiss, Lan, Stover, Alexander E, Schwartz, Philip H, Berg, Bethany, Cheng, Cheng, Parikh, Sumit, Conner, Blair R, Wu, Sitao, Hasso, Anton N, Scott, Daryl A, Koenig, Mary Kay, Karam, Rachid, Tang, Sha, Smith, Moyra, Chao, Elizabeth, Balk, Janneke, Hatchwell, Eli and Eis, Peggy S (2020) NUBPL mitochondrial disease: new patients and review of the genetic and clinical spectrum. Journal of Medical Genetics. ISSN 0022-2593

[img] PDF (Accepted_Manuscript) - Submitted Version
Restricted to Repository staff only until 9 June 2021.

Download (912kB) | Request a copy

Abstract

Background: The nucleotide binding protein-like (NUBPL) gene was first reported as a cause of mitochondrial complex I deficiency (MIM 613621, 618242) in 2010. To date, only eight patients have been reported with this mitochondrial disorder. Five other patients were recently reported to have NUBPL disease but their clinical picture was different from the first eight patients. Here, we report clinical and genetic findings in five additional patients (four families). Methods: Whole exome sequencing was used to identify patients with compound heterozygous NUBPL variants. Functional studies included RNA-Seq transcript analyses, missense variant biochemical analyses in a yeast model (Yarrowia lipolytica) and mitochondrial respiration experiments on patient fibroblasts. Results: The previously reported c.815-27T>C branch-site mutation was found in all four families. In prior patients, c.166G>A [p.G56R] was always found in cis with c.815-27T>C, but only two of four families had both variants. The second variant found in trans with c.815-27T>C in each family was: C.311T>C [p.L104P] in three patients, c.693+1G>A in one patient and c.545T>C [p.V182A] in one patient. Complex I function in the yeast model was impacted by p.L104P but not p.V182A. Clinical features include onset of neurological symptoms at 3-18 months, global developmental delay, cerebellar dysfunction (including ataxia, dysarthria, nystagmus and tremor) and spasticity. Brain MRI showed cerebellar atrophy. Mitochondrial function studies on patient fibroblasts showed significantly reduced spare respiratory capacity. Conclusion: We report on five new patients with NUBPL disease, adding to the number and phenotypic variability of patients diagnosed worldwide, and review prior reported patients with pathogenic NUBPL variants.

Item Type: Article
Uncontrolled Keywords: clinical genetics,metabolic disorders,molecular genetics,neurology,genetics,genetics(clinical) ,/dk/atira/pure/subjectarea/asjc/1300/1311
Faculty \ School: Faculty of Science > School of Biological Sciences
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 20 Aug 2020 01:08
Last Modified: 22 Sep 2020 23:53
URI: https://ueaeprints.uea.ac.uk/id/eprint/76503
DOI: 10.1136/jmedgenet-2020-106846

Actions (login required)

View Item View Item